Asia stocks mixed on Ebola and China concerns

<p> Investors worried about a new case of Ebola on US soil and weak China data.</p>

Asian stocks fell today (October 24th) on investors' concerns over Ebola and China.

New China data showed new home prices fell 1.3 per cent on year in September, the first annual drop in nearly two years. 

This comes after HSBC's factory purchasing managers index rose to 50.4 in October in China from 50.2 the previous month, but the output sub-index slipped to a five month low. "While the manufacturing sector likely stabilised in October, the economy continues to show signs of insufficient effective demand," HSBC said.

Meanwhile, a doctor in New York tested positive for the Ebola virus, the New York Times reported early today, after returning from West Africa last week. 

Tokyo closed up 1.01 per cent at 15,291.64, due to the US dollar's rise against the yen. Seoul fell 0.31 per cent to finish at 1,925.69. Japan’s Topix (TPX) index rose 0.8 per cent, while Australia’s S&P/ASX 200 Index added 0.5 per cent. Hong Kong’s Hang Seng Index fell 0.1 per cent.

Learn about the Asian markets and CFD trading at City Index.

Join our live webinars for the latest analysis and trading ideas. Register now

GAIN Capital UK Limited (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.